Factor XI inhibitor

Factor XI inhibitor · Suzhou Alphamab Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Factor XI inhibitor, covering 2025-09-17 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty [Phase 2]

See pricing